Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Transdermal Drug Delivery: Patches, Gels, Active Systems, Therapeutics, Markets' returned 9 results - Page 1 of 1  FEATURED RESULTS Drug Delivery in Cancer - Technologies, Markets and Companies Cardiovascular Drug Delivery - Technologies, Markets and Com... Pulmonary Drug Delivery Technologies - Global Strategic Busi... Evolving Approaches for Protein Drug Delivery Transdermal Drug Delivery - Technologies, Markets, and Compa...   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Transdermal Pain Management to 2015: Markets, Demand Factors, Opportunities and Forecasts   Greystone Associates, Dec 2010 vs Active Delivery Systems - Transdermal Pain Management Gels - Transdermal Formulations - IP and Proprietary Technology - Limitations of Topical Gels Transdermal Pain Management Product Assessments Pediatric Drug Delivery: Technology and Product Opportunities, 2nd Edition   MCD Group LLC, Oct 2010, Pages: 251 Pain Management Anti-Infectives Respiratory / Allergy Attention Deficit Hyperactivity Disorder Epilepsy Market Size Key Therapeutic Areas CNS Allergies Asthma Infections 3. Drug Delivery Systems Nanoparticle Drug Delivery Market Report   Cientifica Ltd., Sep 2007, Pages: 301 Technologies’ Transdermal Patches By Using Halloysite Nanotubes Technology Case Study -- The Interstitial NanoSystems’ Transdermal Nanoparticle Delivery INJECTABLE DELIVERY Case Study -- Biophan Technologies Top 10 Drug Delivery Technologies (2010 - 2015)   Markets and Markets, Feb 2011, Pages: 264 STUDY GOALS AND OBJECTIVES: - To define and measure drug delivery market and its various sub-segments with respect to types of systems, by mode of drug delivery, by therapeutics and others Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2010   Life Science Intelligence, Inc., Jan 2011 with cytotoxic drug - Needleless/transdermal delivery system for insulin, analgesics, or vaccines with on/off control of dosing - Implantable patient alerting system for the detection and prevention of heart Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2009   Life Science Intelligence, Inc., Dec 2009, Pages: 1763 - Enteric Dialysis with Kibow Biotics - a food-grade microbial Gel cap formulation towards kidney failure applications - Intelligent nasal drug delivery devices for topical, systemic and nose-to-brain The Nanotechnology Opportunity Report (NOR) 2008, 3rd Edition   Cientifica Ltd., June 2008, Pages: 1027 DRUG DELIVERY SYSTEM BY THERAPEUTICS THERAPY Cancer Therapy Study Purpose And Background The Need For A New Approach To Cancer About Drug Delivery System (DDS) Features Of DDS Technologies Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011   Life Science Intelligence, Inc., Dec 2011, Pages: 605 Epidermal System) - a novel transdermal delivery device for high molecular weight drugs, that can be used by medical personnel or the patient - Ozone injection system for multiple spinal applications Emerging Medical Technologies (EMT) Database   Life Science Intelligence, Inc., July 2007 implants, structured TPN lipids, cell therapy for cancer, etc. Company 201 - Immediate, active, device-less, and painless topical drug delivery, of small/macromolecules, for local/systemic indications Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network